These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26545203)

  • 41. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bosom Buddies: The Symbiotic Relationship Between Infants and Bifidobacterium longum ssp. longum and ssp. infantis. Genetic and Probiotic Features.
    Arboleya S; Stanton C; Ryan CA; Dempsey E; Ross PR
    Annu Rev Food Sci Technol; 2016; 7():1-21. PubMed ID: 26934170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
    Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children.
    Mogna L; Del Piano M; Mogna G
    J Clin Gastroenterol; 2014; 48 Suppl 1():S37-9. PubMed ID: 25291125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of mother's intestinal microbiota on gut colonization in the infant.
    Grönlund MM; Grześkowiak Ł; Isolauri E; Salminen S
    Gut Microbes; 2011; 2(4):227-33. PubMed ID: 21983067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula.
    Haarman M; Knol J
    Appl Environ Microbiol; 2005 May; 71(5):2318-24. PubMed ID: 15870317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota.
    Enomoto T; Sowa M; Nishimori K; Shimazu S; Yoshida A; Yamada K; Furukawa F; Nakagawa T; Yanagisawa N; Iwabuchi N; Odamaki T; Abe F; Nakayama J; Xiao JZ
    Allergol Int; 2014 Dec; 63(4):575-85. PubMed ID: 25056226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
    Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial.
    Merenstein DJ; Smith KH; Scriven M; Roberts RF; Sanders ME; Petterson S
    Eur J Clin Nutr; 2010 Jul; 64(7):685-91. PubMed ID: 20216564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
    Bunesova V; Lacroix C; Schwab C
    BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease.
    Kwak DS; Jun DW; Seo JG; Chung WS; Park SE; Lee KN; Khalid-Saeed W; Lee HL; Lee OY; Yoon BC; Choi HS
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1353-9. PubMed ID: 25244414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.
    Mohan R; Koebnick C; Schildt J; Mueller M; Radke M; Blaut M
    Pediatr Res; 2008 Oct; 64(4):418-22. PubMed ID: 18552710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial.
    Holscher HD; Czerkies LA; Cekola P; Litov R; Benbow M; Santema S; Alexander DD; Perez V; Sun S; Saavedra JM; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):106S-17S. PubMed ID: 22237870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
    Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
    J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
    Merenstein DJ; Tan TP; Molokin A; Smith KH; Roberts RF; Shara NM; Mete M; Sanders ME; Solano-Aguilar G
    Gut Microbes; 2015; 6(1):66-77. PubMed ID: 25569274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bifidobacterium longum subsp. infantis CECT 7210 (B. infantis IM-1®) shows activity against intestinal pathogens].
    Moreno-Muñoz JA; Martín-Palomas M; Jiménez López J
    Nutr Hosp; 2022 Sep; 39(Spec No3):65-68. PubMed ID: 36039996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.
    Rao S; Esvaran M; Chen L; Kok C; Keil AD; Gollow I; Simmer K; Wemheuer B; Conway P; Patole S
    Pediatr Res; 2023 Jan; 93(1):49-55. PubMed ID: 35505080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.
    Sangkanjanavanich S; Pradubpongsa P; Mitthamsiri W; Sangasapaviliya A; Boonpiyathad T
    Ann Allergy Asthma Immunol; 2022 Dec; 129(6):790-792. PubMed ID: 36089255
    [No Abstract]   [Full Text] [Related]  

  • 59. Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
    Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
    Nutr J; 2019 Sep; 18(1):54. PubMed ID: 31500629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Herpesvirus Infection in Infants with Gastroschisis.
    Werler MM; Parker SE
    Epidemiology; 2019 Jan; 30(1):e2. PubMed ID: 30299407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.